| Previous Close | 34.06 |
| Open | 34.08 |
| Bid | 34.08 x 13500 |
| Ask | 34.09 x 3500 |
| Day's Range | 34.00 - 34.22 |
| 52 Week Range | 29.83 - 37.39 |
| Volume | 7,668,799 |
| Avg. Volume | 21,575,643 |
| Market Cap | 203.41B |
| Beta | 1.06 |
| PE Ratio (TTM) | 28.69 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.78%) |
| Ex-Dividend Date | 2017-05-10 |
| 1y Target Est | N/A |
- InvestorPlace•3 hours ago
Healthcare Stocks Make a Dumb Move on ‘Trumpcare’
Tenet Healthcare Corp. (NYSE:THC) was up 6.9% on the day; Community Health Systems (NYSE:CYH) was up 5.1%; HCA Healthcare Inc (NYSE:HCA) was up 2.1% and gained another dime per share overnight. UnitedHealth Group Inc (NYSE:UNH) hit an all-time high, adding almost $3 billion to its market cap. Hospitals like Tenet were rallying employees against this bill, because they know that.
- TheStreet.com•3 hours ago
Biotech Movers: Regeneron Slides Back After Big Gains
The main headwind for Regeneron is that Swiss pharma giant Novartis could soon be a rival to the eye drug that drives most of Regeneron's revenue.
- Market Realist•4 hours ago
Vertex on the Street: Analysts’ Recommendations in June 2017
Vertex (VRTX) has planned to submit a new drug application to the FDA in 3Q17 for a Tezacaftor-Ivacaftor combination treatment for cystic fibrosis.
